Filtered by tag: Research Highlights Remove Filter

Nursing and Allied Health Research Priorities in the Care of Patients With Thoracic Malignancies: An International Cross-Sectional Survey

2020    MASCC recently participated in the research and practice study: “Nursing and Allied Health Research Priorities in the Care of Patients With Thoracic Malignancies: An International Cross-Sectional Survey”. The study was carried out by the International Association for the Study of Lung Cancer (IASLC) Nursing & Allied Health Professionals (N&AHP) committee.  The premise of IASLC’s survey was initiated to explore the lack of evidence of research priorities from nurses and allied health professionals working in the field of thoracic malignancies.  This research could provide strategic directions for funders, policy makers, and researchers.  The IASLC has recently published a full report of the survey and conclusions.  The conclusions state there is a clear focus (and need) for research in interventions to improve quality of life and symptom management, particularly for pain, dyspnea, and fatigue was also established, alongside healthcare system issues and screening research.   The full paper is available in open access.  To read, click here.

2020 Clinical Practice Recommendations for the Management of Immune-mediated Adverse Events from Checkpoint Inhibitors

2020    MASCC presents a collection of 2020 clinical practice recommendations for the management of immune-mediated adverse events from checkpoint inhibitors. These recommendations are focused on patients with the most severe toxicities and provide an important international resource and reference in helping improve the management of these presentations.

Read More

MASCC Participates in Japanese Association of Supportive Care in Cancer (JASCC) Virtual 2020 Annual Meeting

2020    MASCC proudly participated in the Japanese Association of Supportive Care in Cancer (JASCC) 5th Annual Meeting held in August.  Originally planned for Kyoto, the meeting was held virtually due to COVID-19.  The meeting included a novel hybrid of both pre-recorded and live sessions. The theme of the meeting was “Diversity, Dialogue and Altruism,” and included the 33rd Annual Meeting of the Japan Psycho-Oncology Society (JPOS) and the 25th Congress of the Japanese Society for Palliative Medicine (JSPM).

Read More

New Guidelines for Managing Mucositis Now Available

2020    Updated clinical practice guidelines for managing mucositis, a very common and often debilitating complication of cancer therapy, was recently published with open access in the journal Cancer. Patients experiencing mucositis often require enteral or parenteral nutrition, consume more opioids, and experience more interruptions to cancer therapy than patients who do not experience mucositis.

Read More

September Editor’s Pick: “A review of factors influencing non-adherence to oral antineoplastic drugs”

2020    Throughout the year, we will share articles from the MASCC journal Supportive Care in Cancer. The “Editor’s Pick” section, chosen by the journal’s Editor-In-Chief, Dr. Fred Ashbury PhD, will cover a variety of topics to meet the many interests of our membership.

Read More

MASCC at ESMO and EONS 2020

2020    MASCC will take part in the 2020 Congress of the European Society for Medical Oncology (ESMO) and the European Nursing Society (EONS), which is being held virtually this year . Don't miss this joint session on 10/17: Established and new treatments, old and new toxicities (in collaboration with MASCC), with chairs, Karin Jordan, MD, of Heidelberg, Germany, and Florian Scotté, MD, PhD, of Villejuif, France. The ESMO session (with MASCC member speakers) will include:

Read More

The Multinational Association of Supportive Cancer Care (MASCC) has published “Supportive care in cancer – a MASCC perspective”

2020    For some years the MASCC Board has recognized the need for a definitive paper that focuses on supportive care in cancer. A group of longstanding MASCC members – Ian Olver, Dorothy Keefe, Jørn Herrstedt, David Warr, Fausto Roila, and Carla Ripamonti – took on this challenge and published “Supportive care in cancer – a MASCC perspective” in the journal Supportive Care in Cancer. "This year sees the 30th anniversary of the formation of MASCC, which makes it timely to review the role of supportive care in oncology practice" says Andrew Davies, MASCC president. "The article highlights the importance of supportive care in facilitating optimal treatment, and equally in maintaining or improving quality of life."

Read More

Editor’s Pick: MASCC Members Publish “Uncertainty upon uncertainty: supportive care for cancer and Covid-19” in the MASCC Journal Supportive Care in Cancer

2020    Throughout the year, we will share articles from the MASCC journal Supportive Care in Cancer. The  “Editor’s Pick” section, chosen by the journal’s Editor-In-Chief, Dr. Fred Ashbury PhD, will cover a variety of topics to meet the many interests of our membership. 

MASCC members recently published the article “Uncertainty upon uncertainty: supportive care for cancer and COVID-19” in the MASCC journal Supportive Care in Cancer. The article addresses the significant negative impact of the current pandemic on the lives of people with cancer, including the struggle to apply data to real-world oncology practice, the heightened uncertainty of cancer patients over the risk of contracting the infection and not being able to receive the recommended cancer treatment, and the adverse effects of COVID-19 on the social support network of cancer patients. 

Read More

Recent Edition of the MASCC Journal Supportive Care in Cancer Features “Resistance exercise and breast cancer–related lymphedema—a systematic review update and meta-analysis”

2020    The MASCC journal Supportive Care in Cancer recently featured a systematic review update and meta-analysis to analyze resistance exercise (RE) intervention trials in breast cancer survivors (BCS) regarding their effect on breast cancer-related lymphedema (BCRL) status and upper and lower extremity strength.

Read More

MASCC Affiliate AICSO Shares Recent Research on Physical Exercise and Cancer Patients

2020    MASCC Member Andreia Capela, MD, of Centro Hospitalar Vila Nova de Gaia, Espinho Santa Iria de Azoia, Portugal, recently shared the research findings of her OncoMove team on the efficacy of a low-cost community-based supervised exercise program in early breast cancer survivors after primary treatment.  OncoMove is part of the of Association of Oncology Research and Support Care (AICSO), a MASCC affiliate.  AICSO is dedicated to the research, implementation and professional qualification on evidence-based supportive care in oncology.  To read more, click here

Recent Articles by MASCC members in Oral Diseases: An Update by Ourania Nicolatou-Galitis

2020    For the benefit MASCC members, Ourania Nicolatou-Galitis, DDS, MSc, DrDent, has shared updates on the publication of two recent articles in Oral Diseases. The first is“Alveolar bone histological necrosis observed prior to extractions in patients, who received bone-targeting agents,” which includes MASCC member study participants Ourania Nicolatou-Galitis, Erofili Papadopoulou, Emmanouil Vardas, Maria Kouri, Dimitra Galiti, and Carla Ripamonti.

Read More

Supportive Cancer Care and COVID-19: a new journal article from the MASCC Survivorship Study Group

2020    This month, we are sharing a recent article published by MASCC members in the MASCC journal Supportive Care in Cancer. With the rapidly changing and evolving practice in managing COVID-19, MASCC would like to share information on our members’ professional experiences amongst our community. If you are interested and able to share your professional experiences, advice and advancements during this time of international crisis, we will find a convenient time in your schedule for a brief 30-minute interview. Please contact Angela Perez today at [email protected].

Read More

MASCC Recommendations for the Management of Constipation in Patients with Advanced Cancer

2019    Constipation is a common problem among patients with advanced cancer, with a reported prevalence of 32–87% in this group, in whom it also causes significant morbidity. Opioid-induced constipation appears to be a chronic side effect and is more common in patients with cancer pain than in those with nonmalignant pain. It may be influenced by the type of opioid involved, as well as by genetic factors, but does not appear to be particularly influenced by the dose of opioid.

Read More

2019 Update: MASCC/ISOO Clinical Practice Guidelines for the Management of Mucositis Secondary to Cancer Therapy

2019    MASCC’s Mucositis Study Group (MSG) has announced the latest update of the MASCC/ISOO Clinical Practice Guidelines for the Management of Mucositis Secondary to Cancer Therapy. An editorial by MSG Chair Sharon Elad, DMD, MSc, and seven articles have just been published (July 2019) in a Special Section of Supportive Care in Cancer (SCC). This is the first set of papers generated as part of this guideline update and it represents several types of interventions for oral mucositis: anti-inflammatory agents; photobiomodulation; vitamins, minerals, and nutritional supplements; and protocols categorized as basic oral care.

Read More

Early Detection of Anthracycline-Induced Cardiotoxicity

2019    Anthracycline therapy is a mainstay for breast cancer and many other cancers, but it is associated with a rate of incident heart failure more than five times the average. Preclinical studies of anthracycline-induced myocardial damage show that the substrate for heart failure is myocardial fibrosis preceded by myocardial edema or inflammation. Loss of endothelial progenitor cells (EPCs) may also contribute to myocardial damage. The detection of early changes via blood biomarkers is challenging. However, recently, cardiac magnetic resonance (CMR) has been successfully used to detect post-treatment anthracycline-induced fibrosis through T1 mapping, paralleling a decline in left ventricular ejection fraction (LVEF).

Read More

Research on Chemotherapy-induced Peripheral Neuropathy

2019    Alex Molassiotis and Alex Chan are among the co-authors of a recent study of risk factors for chemotherapy-induced peripheral neuropathy (CIPN) among patients receiving taxane-based and platinum-based chemotherapy.1 CIPN is a significant side effect of neurotoxic chemo-therapies and one that is difficult to manage. Although several risk factors for CIPN have been identified, methodological limitations in much past research limit knowledge about such risks. Molassiotis and his colleagues undertook this study to assess the relative contributions of a wider range of potential risk factors than previously studied.

Read More

New Clinical Practice Guideline on MRONJ

2019    A new MASCC/ISOO/ASCO Clinical Practice Guideline on Medication-Related Osteonecrosis of the Jaw has been published in the Journal of Clinical Oncology (JCO) by the American Society of Clinical Oncology. (Yarom N et al, J Clin Oncol 2019 Jul 22:JCO1901186. Epub ahead of print). 

Read More

Clinical Course of Venous Thromboembolism May Differ With Cancer Site

2017    Carme Font is one of a large group of investigators who have collaborated on a study of differences in the clinical course of venous thromboembolism (VTE) in relation to specific cancer sites (breast, prostate, colorectal, and lung). The study was based on data from an international registry of patients with VTE,* and included almost 4000 adult patients with active cancer.

Read More

Incidental Venous Thromboembolism in Cancer Patients on Routine CT Scans

2017    In a prospective cohort study, Carmen Escalante et al. investigated the prevalence of incidental venous thromboemtolism (VTE) in almost 1100 adult cancer patients on routine staging CT scans of the chest, abdomen, or pelvis. The research team also documented symptoms associated with incidental VTEs and determined the incidence of VTE recurrence in these patients after 3 and 6 months.

Read More

Exercise, Quality of Life, and Physical Function in Patients with Cancer

2017    MASCC members Paul Jacobsen (Moffitt Cancer Center and Research Institute, Tampa, Florida) and Irma Verdonck-de Leeuw (VU University Medical Center, Amsterdam, The Netherlands) were among the many collaborators on a large-scale meta-analysis (Buffart et al., 2017) designed to evaluate the effects of exercise on quality of life and physical function in adult cancer patients.1 The study also aimed to determine the extent to which demographic, clinical, exercise, and other intervention-related variables moderated the main effects. The analysis included 34 randomized controlled trials that involved more than 4,500 adult cancer patients and that evaluated the effects of exercise on quality of life and physical function. Exercise was found to significantly improve both quality of life and physical function. These effects were unaffected by differences in demographic, clinical, and exercise variables, such as age, sex, education level, marital status, BMI, cancer type, metastatic stage, and treatment. Also, exercise was equally effective during and following cancer treatment.

Read More